|
HMG20A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.75479999999473E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.823100E-04 |
| Normal-vs-Stage2 |
3.921400E-03 |
| Normal-vs-Stage3 |
2.235900E-04 |
| Normal-vs-Stage4 |
9.81070000000139E-05 |
| Stage1-vs-Stage2 |
6.415400E-01 |
| Stage1-vs-Stage3 |
3.433600E-01 |
| Stage1-vs-Stage4 |
1.662580E-01 |
| Stage2-vs-Stage3 |
8.378200E-01 |
| Stage2-vs-Stage4 |
5.953400E-01 |
| Stage3-vs-Stage4 |
6.657200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.46469999999733E-05 |
| Normal-vs-AfricanAmerican |
6.698400E-01 |
| Normal-vs-Asian |
4.155100E-03 |
| Caucasian-vs-AfricanAmerican |
2.070500E-02 |
| Caucasian-vs-Asian |
8.468000E-01 |
| AfricanAmerican-vs-Asian |
6.775700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.843300E-04 |
| Normal-vs-Female |
1.183600E-04 |
| Male-vs-Female |
6.997400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.783900E-04 |
| Normal-vs-Age(41-60Yrs) |
1.660050E-03 |
| Normal-vs-Age(61-80Yrs) |
5.75159999999242E-05 |
| Normal-vs-Age(81-100Yrs) |
1.190320E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.738000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.321200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.237170E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.914000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.052760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.389200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.559800E-03 |
| Classical-VS-Follicular |
5.915700E-02 |
| Classical-VS-Other |
9.964600E-01 |
| Classical-VS-Normal |
1.882360E-03 |
| Tall-VS-Follicular |
4.508600E-01 |
| Tall-VS-Other |
5.016200E-01 |
| Tall-VS-Normal |
2.45849999999104E-05 |
| Follicular-VS-Other |
5.615600E-01 |
| Follicular-VS-Normal |
3.571700E-04 |
| Other-VS-Normal |
2.838800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.358290E-04 |
| Normal-vs-N1 |
1.846050E-04 |
| N0-vs-N1 |
5.329400E-01 |
|
|
